Russia on Wednesday begun the process of clinical trial of a locally developed coronavirus vaccine on human body.
Its Health Ministry said the vaccine will be pushed into human body shortly after necessary preparations, reports AP.
According to a statement, Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology developed the vaccine in two forms – liquid and powder for injections.
It will be applied on trial basis on two groups of volunteers with 38 people each. Later, they will be isolated at two separate hospitals.
The ministry said running clinical trials in the midst of a pandemic is a unique situation. “So unprecedented measures have been taken — all potential participants of the trial ... spent two weeks (quarantined) in a sanatorium for observation."
The first dose of injections is scheduled for Thursday and Friday, it added.
Professor Alexander Gintsburg revealed that he and other researchers had tried the vaccine on themselves before the start of human studies and experienced no side effects. "Everyone is alive and well and cheerful," he added.
However, he then didn't clarify how many people injected themselves with the substance.